THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Y-Intercept (Hong Kong) Ltd's Holding History (CIK: 0001772875)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 18,686 Value ($000) $350 Avg Close $16.59 Range $13.50 - $20.33

Q2 2025

Shares 40,943 Value ($000) $452 Avg Close $9.72 Range $7.90 - $11.82

Q3 2024

Shares 31,194 Value ($000) $251 Avg Close $8.66 Range $7.44 - $10.42

Q3 2023

Shares 16,137 Value ($000) $139 Avg Close $9.65 Range $8.25 - $10.59

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	18,686	$350	$16.59	$13.50 - $20.33
Q2 2025	40,943	$452	$9.72	$7.90 - $11.82
Q3 2024	31,194	$251	$8.66	$7.44 - $10.42
Q3 2023	16,137	$139	$9.65	$8.25 - $10.59